Citichem India

Citichem India

LISTED

IPO Date: 27 Dec - 31 Dec 2024

Listing Date: 3 Jan 2025

Price Range

₹70 - ₹70 per share

Issue Size

12 Cr

Min Investment

₹2,80,000

2 lots minimum (SEBI rule for SME)

Min Application

4000 Shares

2000 per lot × 2

View IPO Document

Schedule of Citichem India

Issue open date

27 Dec 2024

Issue close date

31 Dec 2024

UPI mandate deadline

31 Dec 2024 (5 PM)

Allotment finalization

1 Jan 2025

Share credit

2 Jan 2025

Listing date

3 Jan 2025

Mandate end date

15 Jan 2025

Issue size

Funds Raised in the IPOAmount
Overall12 Cr
Fresh Issue0 Cr
Offer for Sale0 Cr

Allotment DetailsNew

Allotment TimelineDetails
Allotment Date1 Jan 2025
Allotment Link{Link}

Grey Market Premium

New

Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.

DateIPO PriceGMPEst. Listing Price
3 Jan 2025Latest₹70₹15₹85(+21%)
2 Jan 2025₹70₹15₹85(+21%)
1 Jan 2025₹70₹20₹90(+28%)
31 Dec 2024₹70₹20₹90(+28%)
30 Dec 2024₹70₹20₹90(+28%)
28 Dec 2024₹70₹29₹99(+42%)
27 Dec 2024₹70₹29₹99(+42%)
26 Dec 2024₹70₹29₹99(+42%)

Performance Citichem India

Issue PriceListing GainCurrent Market PriceP/L
₹70 - ₹70 per share₹ 68 (-2.46%) ₹ 12.74-81.80%

About Citichem India

Incorporated in 1992, Citichem India Limited specializes in procuring and supplying organic and inorganic chemicals, bulk drugs, and food chemicals primarily to the pharmaceutical industry. Its diverse portfolio caters to industries like aluminium, steel, textiles, dairy, paints, dyes, soaps, and adhesives. With over 25 years of promoter expertise, the company aims to expand its market presence and diversify procurement channels, leveraging its established clientele and growing demand for speciality chemicals.

Founded in1992
Managing directorMr. Arif Esmail Merchant
Parent organizationCitichem India Ltd

Financial Overview

Strengths

4
  1. 1

    25+ years of experience in specialty chemicals.

  2. 2

    Diverse portfolio serving multiple industries.

  3. 3

    Strong client relationships ensure steady demand.

  4. 4

    Promoters excel in supply chain management.

Risks

4
  1. 1

    Reliance on leased facilities limits scalability.

  2. 2

    Vulnerable to raw material price fluctuations.

  3. 3

    Regulatory risks in chemicals and pharma.

  4. 4

    Legal issues may affect reputation and confidence.

Subscription Figures

CategorySubscription (No. of times)
Qualified Institutional Buyers (QIBs)N/A
Non-Institutional Investors (NIIs)277
Retail Individual Investors (RIIs)543
EmployeeN/A
Total414